GB779257A - Improvements in or relating to antibiotics and the preparation thereof - Google Patents
Improvements in or relating to antibiotics and the preparation thereofInfo
- Publication number
- GB779257A GB779257A GB14544/54A GB1454454A GB779257A GB 779257 A GB779257 A GB 779257A GB 14544/54 A GB14544/54 A GB 14544/54A GB 1454454 A GB1454454 A GB 1454454A GB 779257 A GB779257 A GB 779257A
- Authority
- GB
- United Kingdom
- Prior art keywords
- per cent
- meal
- oleandomycin
- chloroform
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Abstract
<PICT:0779257/IV(b)/1> <PICT:0779257/IV(b)/2> A new antibiotic oleandomycin (originally referred to as PA 106 and also called amimycin) is produced by cultivating Streptomyces antibioticus ATCC 11891, or a mutant thereof, in an aqueous nutrient medium under submerged aerobic conditions until substantial anti-bacterial activity is imparted to the medium. A temperature of 24 DEG to 30 DEG C. and period of 1 to 4 days is suitable. The medium contains (a) a source of carbohydrate, e.g. sugars, starch, glycerol and corn meal; (b) a source of nitrogen, e.g. casein, soybean meal, peanut meal, wheat gluten, cottonseed meal, lactalbumin, enzymatic digest of casein and tryptone; (c) a source of growth substance, e.g. distillers' solubles, yeast extract and molasses fermentation residues; (d) mineral salts such as sodium chloride, potassium phosphate, sodium nitrate, magnesium sulphate; and (e) trace metals such as copper, zinc and iron. A buffer, e.g. calcium carbonate and anti-foaming agent, may be present. After removal of the mycelium a crude product is obtained by drying the residual broth. Oleandomycin is isolated from the liquid broth by (A) solvent extraction or (B) adsorption. Solvent extraction is at pH 6 to 10 by means of water-immiscible solvents such as diethyl ether, benzene, toluene, ethyl acetate, butyl acetate, methyl isobutyl ketone, butanol and chloroform. Purification is obtained by treating the extract with water of below pH 2.5 and re-extracting the solution with the organic solvent as pH 6 to 10. The anti-biotic may be recrystallized from ethyl acetate, chloroform methylene chloride or ethylene dichloride. Adsorption is on (a) charcoal, (b) ion-exchange resin, or (c) alumina. Oleandomycin is a basic white amorphous compound; effective in inhibiting the growth of gram-positive bacteria and mycobacteria; forms salts with acids such as hydrochloric, sulphuric and phosphoric acid; soluble in water, methyl alcohol, ethyl alcohol, acetone and butanol, insoluble in hexane, carbon tetrachloride and di-n-butyl ether; the crystalline hydrochloride (a) melts at 134 DEG to 135 DEG C.; (b) contains 57.63 per cent carbon, 8.73 per cent hydrogen, 1.87 per cent nitrogen, 4.30 per cent chlorine and 27.47 per cent oxygen, probably C35H67NO12.HCl; (c) exhibits a broad, low intensity peak in the ultra-violet region at 286-289 mm ; (d) suspended in a potassium bromide pellet shows peaks in the infra-red at the following frequencies: 3380, 2940, 2890, 1710, 1640, 1465, 1380, 1330, 1190, 1160, 1115, 1075, 1055, 1010, 985, 935, 865 and 828 cm-1, hydrochloride dissolved in methanol: <FORM:0779257/IV(b)/1> molecular weight of base is approximately 715; in chloroform the base exhibits characteristic absorption in infra-red at 3510, 2910, 2890, 2840, 2790, 1710, 1460, 1385, 1335, 1305, 1280, 1180, 1160, 1110, 1075, 1050, 1005, 985, 960, 935, 895, 885 and 886 cm.-1. Hydrochloride may be produced by passing hydrogen chloride gas into an acetone solution of the base.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US779257XA | 1953-06-01 | 1953-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB779257A true GB779257A (en) | 1957-07-17 |
Family
ID=22140824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB14544/54A Expired GB779257A (en) | 1953-06-01 | 1954-05-18 | Improvements in or relating to antibiotics and the preparation thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB779257A (en) |
-
1954
- 1954-05-18 GB GB14544/54A patent/GB779257A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3150059A (en) | Penicillin deacylation via actinoplanaceae fermentation | |
US3178341A (en) | Antibiotics tylosin and desmycosin and derivatives thereof | |
EP0379395B1 (en) | Antibiotic L53-18A and process for preparation thereof | |
US2928844A (en) | Celesticetin, its salts and method of preparation | |
GB1339032A (en) | Rabelomycin and processes for its production | |
GB844289A (en) | Pimaricin and process of producing same | |
US3616228A (en) | Beta-substituted propionic acids and method of making the same | |
GB779257A (en) | Improvements in or relating to antibiotics and the preparation thereof | |
GB765886A (en) | A new antibiotic ristocetin and a method of producing same | |
US3676300A (en) | Method for producing monoacyl derivatives of antibiotic t-2636c | |
US2916483A (en) | Methymycin | |
US3980522A (en) | Production of a new antibiotic, calvatic acid | |
US4009155A (en) | P-carboxyphenyl-azoxycarbonitrile and its methyl ester | |
GB729208A (en) | Improvements in or relating to a new antibiotic p.a. 95 and the preparation thereof | |
US4353986A (en) | Process for producing antibiotic nanaomycin E | |
US3795668A (en) | Polyamine compounds and methods for their production | |
GB1020967A (en) | Improvements in or relating to the biochemical production of ribosides or ribotides | |
GB793797A (en) | Improvements in or relating to antibiotics | |
GB768364A (en) | A new antibiotic anisomycin | |
US4293649A (en) | Process for production of antibiotic A-33853 | |
GB764198A (en) | The antibiotic vengicide and processes for the preparation of the antibiotics oxytetracycline and vengicide | |
GB819872A (en) | The new antibiotics p.a. 114a and p.a. 114b | |
US3923979A (en) | Antibiotic 60-6 and production thereof | |
GB708686A (en) | Antibiotic d-13 and its production | |
GB732150A (en) | Improvements in or relating to antibiotics |